Fundz

Accelus raised growth equity funding led by Concord Health Partners to support its commercial growth and development of spinal implant technologies.

PRIVATEMay 29, 2025

Round Type

Private Equity

Palm Beach GardensManufacturingHealth Care

Investors

Concord Health Partners

Description

Accelus, a Palm Beach Gardens, FL-based medical technology company, has raised an undisclosed amount in growth equity funding. The round was led by Concord Health Partners. The company intends to use the funds to support its continued commercial growth and further development of its differentiated spinal implant technologies. Led by President and CEO Kevin McGann, Accelus specializes in expandable spinal implant technology.

Quick answer

Accelus raised an undisclosed amount in a Private Equity round, dated May 29, 2025. Investors: Concord Health Partners. Accelus is based in Palm Beach Gardens, Florida, United States.

How much did Accelus raise?
Accelus raised an undisclosed amount in a Private Equity round on May 29, 2025.
Who invested in Accelus?
Concord Health Partners is named as investors in this round.
What does Accelus do?
Accelus is redefining spine surgery through a procedure-centric approach that prioritizes both surgeon experience and patient outcomes.
Where is Accelus based and how big is it?
Accelus is based in Palm Beach Gardens, Florida, United States. Fundz records about 67 employees.
Who are the decision-makers at Accelus?
Fundz holds 1 contact at Accelus. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Health Care around the same time

Companies in the same sectors as Accelus that raised within 45 days of this round, from Fundz verified event records.

  • Harvard Apparatus Regenerative Technology raised $2M (Seed) on July 11, 2025.
  • Loopworm raised $3.3M (Pre-Series A) on July 2, 2025.
  • Helus Pharma raised $50M on June 30, 2025.
  • USpharma Ltd raised an undisclosed amount (Private Equity) on June 30, 2025.
  • Armis Biopharma raised $1M (Seed) on June 27, 2025.
  • NewcelX raised $1M (Seed) on June 27, 2025.

Who to call at Accelus, and when

A new round usually means Accelus is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Accelus raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Accelus, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Accelus. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Accelus

Location

Palm Beach Gardens, Florida, United States

About

Accelus is redefining spine surgery through a procedure-centric approach that prioritizes both surgeon experience and patient outcomes. Focused on innovation and excellence, Accelus delivers advanced Adaptive Geometry™ technologies tailored for TLIF, PLIF, endoscopic-assisted percutaneous, and lateral spine procedures. Every implant and instrument is purposefully engineered to streamline surgical workflows and support better clinical results, empowering spine surgeons with precision tools for today’s evolving surgical landscape.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Accelus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Accelus's next move

See what Strategic adds

Accelus raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.